Provider review
PlushCare tirzepatide review
What PlushCare charges, what is included, who prescribes, which pharmacy fills it, where it operates — and how much of that we confirmed ourselves rather than took from the website.
Read on PlushCare’s own pages on November 21, 2026: no compounded tirzepatide. It scores 65/100 under our written v4.1 scoring guide, #13 of 22 programs scored.
What is distinctive about this programme
The cheapest membership in the category, by a distance
At $19.99 a month, PlushCare's membership is a fraction of the $74 to $149 charged by other brand-focused platforms. For a patient who wants clinical oversight alongside manufacturer-priced brand medication, that is the lowest overhead available in our dataset.
Zepbound at $299 plus $19.99 gives $319 all-in against $348 to $448 at Hims, Hers, Ro and Found for comparable brand access. The membership difference compounds: $240 a year against $1,788 at a $149 membership.
The initial visit fee is billed separately
A $129 initial visit fee applies and is not included in the monthly figures. On a first year, that is roughly equivalent to six additional months of membership, and it is the kind of one-off charge that sits outside most published comparisons — including, until now, ours.
Two listings are at retail level
PlushCare's dataset entries include brand Wegovy at roughly $1,000 medication plus membership, and brand Mounjaro at roughly $1,100 plus membership. NovoCare sells Wegovy direct for $349. Lilly runs no self-pay programme for Mounjaro, but Zepbound is the same molecule at $299 to $449.
The Zepbound pass-through pricing is genuinely competitive. The retail-level listings for other brands are not, and the difference between the two on the same platform is the reason to check the manufacturer before every purchase.
Show this figure as a table
| Item | Value | Evidence |
|---|---|---|
| Tirzepatide brand injectable, FDA-approved | $319 | Provider-reported |
Where it holds up
- Lowest membership in the category at $19.99 a month
- Zepbound pricing passes through manufacturer rates rather than marking them up
- All-in Zepbound total of $319 undercuts every other brand-focused platform in our dataset
- First month of membership is reported free on some plans
Where it does not
- A separate $129 initial visit fee applies and is not in the monthly figure
- Wegovy and Mounjaro listings are at retail level, several times manufacturer-direct pricing
- Brand pricing escalates by dose tier, reaching $449 plus membership
- Figures are third-party reported and not yet captured by us
| Field | Position |
|---|---|
| Membership | Separate and required |
| Dose structure | Escalates with dose or not established |
| Lowest captured figure | $319/mo, month-to-month |
| Evidence status | Third-party reported, pending our own capture |
| Pharmacy named to us | No — provider-reported only |
| Category | Points |
|---|---|
| Pricing transparency | 20 |
| Total annual cost | 20 |
| Clinical oversight | 15 |
| Pharmacy transparency | 15 |
| Support | 10 |
| Regulatory disclosure | 10 |
| Accessibility | 10 |
Pricing, all-in
Plan total and monthly equivalent are calculated by us from the provider's published figures, using the same formula applied to every provider on this site. A price is only a price once the required fees are inside it.
| Provider | Program | Formulation | Dose coverage | Medication | Required fees | All-in monthly | Price type | Evidence | Captured |
|---|---|---|---|---|---|---|---|---|---|
| PlushCare | month_to_month | brand injectable, FDA-approved | not recorded | $319 | not verified | $319 | Recurring | Provider-reported | 2026-07-06 |
How this sits against the market
The July 2026 all-provider chart that stood here has been retired. Current first-party prices for 28 compounded tirzepatide programs (read October 15, 2026; NexLife November 20, 2026) are on the price index.
Show this figure as a table
| Component | Amount |
|---|---|
| Medication | not captured |
| Membership | not captured |
| Shipping | not captured |
| Dose surcharge | not captured |
| Consultation | not captured |
| Labs | not captured |
| All-in total | not captured |
| Cost component | Inside the advertised figure? | Charged anyway? |
|---|---|---|
| Medication | yes | yes |
| Membership or program fee | no | not verified |
| Shipping | no | not verified |
| Higher-dose surcharge | no | not verified |
| Initial consultation | no | not verified |
| Required laboratory work | no | not verified |
| Cancellation or restocking terms | no | not verified |
This chart stays empty until two or more dated captures exist. Historical values are never estimated or backfilled from a provider's current page.
Show this figure as a table
| Item | This provider | Category median |
|---|---|---|
| All-in monthly | not captured | not captured |
| Membership fee | not captured | not captured |
| Rubric score | not captured | not captured |
What is included, and what is not
Where it holds up
- nothing verified yet
Where it does not
- nothing verified yet
Where it operates
State availability is verified against the provider's own checkout or a support confirmation, state by state, with a capture date. A provider serving forty states is not nationwide, and we do not describe it that way.
Show this figure as a table
| Status | Records | Share |
|---|---|---|
| Researched and verified | 0 | 0% |
| Not yet researched | 51 | 100% |
Pharmacy and fulfilment
What changed
Show this figure as a table
| No events recorded. |
- no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.
How this compares to the category
Once enough providers are scored, this section reports where PlushCare sits against the median for each rubric category, not against a hand-picked competitor.
| Question | Worth | Their answer | Status |
|---|---|---|---|
| Pharmacy traceability and quality disclosures | 15 pts | not verified | Not answered Verification pending |
| Clinical oversight and care continuity | 20 pts | not verified | Not answered Verification pending |
| State access and operational reliability | 10 pts | not verified | Not answered Verification pending |
| Cancellation, billing and support transparency | 10 pts | not verified | Not answered Verification pending |
Questions readers actually ask
Is PlushCare the cheapest option?
Read on its own page on November 21, 2026: no compounded tirzepatide; membership $19.99 a month (or $149 a year) plus $129 per visit without insurance; brand medication billed by your pharmacy.
Is compounded tirzepatide the same as Zepbound?
PlushCare scores 65/100 under the written v4.1 scoring guide, #13 of 22 programs scored from pages read November 20–21, 2026. Its weakest category is total annual cost (5 of 20).
Related on this site
- All provider reviewsProviders
- NexLife Tirzepatide ReviewProviders
- Ro Body Tirzepatide ReviewProviders
- Hims & Hers Tirzepatide ReviewProviders
- The 100-point rubricCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- Ro Body vs Mochi HealthComparisons
- Mochi Health Tirzepatide ReviewProviders
- Eden Tirzepatide ReviewProviders
Related coverage
GLP-1 Tirzepatide Review. “PlushCare Tirzepatide Review.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/providers/plushcare/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.